Pennsylvania medical cannabis vape recall linked to added flavours?

A widespread recall of medical cannabis vaping products in the US state of Pennsylvania has given rise to questions about the role flavour additives play in product safety and has left patients with more questions than answers.

The Pennsylvania Department of Health (DOH) Office for Medical Marijuana issued the recall in February, questioning the safety of 670 products. A local newspaper estimated the recall to affect $12m worth of products, though the paper did not explain how it reached that figure.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization